HDAC2-LTA4H-

Kai Ye1, Jixuan Li2, Zhixiao Huo1

  • 1Clinical School of the Second People's Hospital, Tianjin Medical University, Tianjin 300192, China; Tianjin Institute of Hepatology, Tianjin Second People's Hospital, Tianjin 300192, China; Tianjin Integrated Traditional Chinese and Western Medicine Institute of Infectious Diseases, Tianjin 300192, China.

概括

基因组脱乙酶2 (HDAC2) 抑制剂BRD6688通过调节白血A4酶 (LTA4H) 和巨分化来减轻急性损伤 (AKI),为病提供了潜在的治疗策略.